Key Financial Data Of Reporting Company

Cyfuse Biomedical K.K. - Filing #7272238

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
54,446,000 JPY
61,112,000 JPY
374,477,000 JPY
708,245,000 JPY
137,484,000 JPY
Ordinary profit (loss)
-869,747,000 JPY
-586,187,000 JPY
-433,165,000 JPY
144,914,000 JPY
-327,492,000 JPY
Profit (loss)
-872,238,000 JPY
-589,211,000 JPY
-473,962,000 JPY
142,905,000 JPY
-329,501,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
1,364,728,000 JPY
1,283,445,000 JPY
1,272,005,000 JPY
100,000,000 JPY
100,000,000 JPY
Total number of issued shares
8,184,800 xbrli:shares
7,894,300 xbrli:shares
7,773,300 xbrli:shares
1,001 xbrli:shares
1,001 xbrli:shares
Net assets
2,542,406,000 JPY
3,203,469,000 JPY
3,769,801,000 JPY
1,900,114,000 JPY
1,549,458,000 JPY
Total assets
3,518,001,000 JPY
4,214,809,000 JPY
4,815,337,000 JPY
2,646,232,000 JPY
2,196,213,000 JPY
Net assets per share
304.60
405.71
484.88
-5,183.91
-5,469.44
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-108.34
-75.42
-177.67
285.53
-658.34
Diluted earnings per share
Equity-to-asset ratio
0.709 xbrli:pure
0.760 xbrli:pure
0.783 xbrli:pure
0.718 xbrli:pure
0.705 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
0.083 xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-760,553,000 JPY
-562,296,000 JPY
-403,596,000 JPY
161,537,000 JPY
-294,001,000 JPY
Net cash provided by (used in) investing activities
-8,637,000 JPY
-19,474,000 JPY
-430,674,000 JPY
-50,583,000 JPY
-264,000 JPY
Net cash provided by (used in) financing activities
-52,012,000 JPY
18,236,000 JPY
2,658,538,000 JPY
229,206,000 JPY
488,905,000 JPY
Cash and cash equivalents
2,052,570,000 JPY
2,873,773,000 JPY
3,437,307,000 JPY
1,613,040,000 JPY
1,272,879,000 JPY
Number of employees
21 xbrli:pure
21 xbrli:pure
21 xbrli:pure
22 xbrli:pure
19 xbrli:pure
Average number of temporary employees
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
2 xbrli:pure
2 xbrli:pure
Total shareholder return
0.347 xbrli:pure
0.586 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Total return on share price index
0.882 xbrli:pure
0.967 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.